Physician profile
Frederick A Barber
NPI 1659475242
$2,048.12
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,046 · 2020: $690 · 2021: $297 · 2022: $15.76.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $380.07 | 2019-2020 | |
| Lilly USA, LLC | $351.11 | 2019-2021 | |
| Novo Nordisk INC | $198.22 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $185.65 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $152.39 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $151.10 | 2019-2021 | |
| Allergan, INC. | $131.16 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $110.06 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.55 | 2019-2021 | |
| Amarin Pharma, INC. | $87.60 | 2020-2021 | |
| Astellas Pharma US INC | $56.11 | 2019-2021 | |
| Abbvie INC. | $44.86 | 2021-2022 | |
| Glaxosmithkline, LLC. | $42.50 | 2019-2020 | |
| Amgen INC. | $31.06 | 2019 | |
| Esperion Therapeutics, INC. | $17.68 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Barber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.